Hugh Cathey is the CEO of ChromoCare, which is a leader in the field of Pharmacogenetics (PGx), aka the genetic testing of patients to ensure compatibility with prescription medications. Prior to ChromoCare, Hugh served as a Principal for Columbus-Partners, LLC, and CRO at Healthspot, Inc. Additionally, he has a wide range of leadership experience at several other companies, and is an experienced investor and board member at several firms.